Capstone Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$919K Buy
6,410
+70
+1% +$9.41K 0.03% 618
2017
Q1
$794K Buy
6,340
+170
+3% +$19.7K 0.02% 665
2016
Q4
$695K Sell
6,170
-780
-11% -$90.4K 0.02% 734
2016
Q3
$894K Sell
6,950
-130
-2% -$15.6K 0.03% 629
2016
Q2
$774K Sell
7,080
-6,320
-47% -$629K 0.02% 685
2016
Q1
$1.27M Sell
13,400
-560
-4% -$47.3K 0.04% 521
2015
Q4
$1.26M Sell
13,960
-560
-4% -$47.5K 0.04% 530
2015
Q3
$1.35M Buy
14,520
+620
+4% +$54.6K 0.04% 470
2015
Q2
$914K Sell
13,900
-8,090
-37% -$538K 0.03% 620
2015
Q1
$1.57M Buy
21,990
+380
+2% +$20.6K 0.04% 478
2014
Q4
$822K Sell
21,610
-4,000
-16% -$126K 0.02% 739
2014
Q3
$636K Buy
25,610
+370
+1% +$9.37K 0.02% 843
2014
Q2
$635K Buy
25,240
+2,208
+10% +$51.4K 0.02% 885
2014
Q1
$600K Sell
23,032
-350
-1% -$9.68K 0.02% 926
2013
Q4
$625K Buy
23,382
+5,150
+28% +$127K 0.02% 944
2013
Q3
$348K Buy
18,232
+650
+4% +$14.9K 0.01% 1561
2013
Q2
$379K Buy
+17,582
New +$353K 0.01% 1418

Other funds holding ABMD

Capstone Asset Management's ABMD Position: Q2 2017 in Review

Capstone Asset Management increased its Abiomed Inc (ABMD) stake by 1.1% in Q2 2017, buying an estimated $9.41K and bringing the position to 6,410 shares worth $919K. The position accounts for 0.03% of the portfolio, ranked #618.

Capstone Asset Management first reported a position in ABMD in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.57M in Q1 2015. 303 funds tracked by Wall St. Rank hold ABMD as of Q2 2017.

  • Capstone Asset Management held 6,410 shares of Abiomed Inc worth $919K as of Q2 2017.
  • Capstone Asset Management bought 70 Abiomed Inc shares in Q2 2017, an estimated $9.41K.
  • Abiomed Inc made up 0.03% of Capstone Asset Management's portfolio in Q2 2017, its #618 holding.
  • Capstone Asset Management first reported a position in Abiomed Inc in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Abiomed Inc position peaked at $1.57M in Q1 2015.
  • 303 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.